Apexigen, Inc.
APGN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Market Cap | $13,495 | $311,017 | $330,903 |
| - Cash | $14,802 | $23,443 | $25,284 |
| + Debt | $106 | $510 | $1,156 |
| Enterprise Value | -$1,201 | $288,084 | $306,775 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$32,576 | -$28,852 | -$24,417 |
| % Margin | – | – | – |
| Net Income | -$31,452 | -$28,875 | -$23,702 |
| % Margin | – | – | – |
| EPS Diluted | -1.59 | -0.93 | -0.76 |
| % Growth | -71% | -22.4% | – |
| Operating Cash Flow | -$30,693 | -$23,902 | -$19,957 |
| Capital Expenditures | -$57 | -$54 | $0 |
| Free Cash Flow | -$30,750 | -$23,956 | -$19,957 |